Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GRA-H5255 | Human | Human GM-CSF R alpha Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
GRA-H52H7 | Human | Human GM-CSF R alpha Protein, His Tag (SPR verified) | ![]() |
![]() ![]() |
![]() ![]() |
Human GM-CSF R alpha, His Tag (SPR verified) (Cat. No. GRA-H52H7) captured on CM5 Chip via anti-His antibody, can bind Human GM-CSF, Tag Free (Cat. No. GMF-H4214) with an affinity constant of 16.1 nM as determined in SPR assay (Biacore T200) (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Mavrilimumab | CAM-3001; KPL-301; GM-CSFR; CAM3001 | Phase 3 Clinical | Csl Ltd | Giant Cell Arteritis; Arthritis, Rheumatoid; Coronavirus Infections | Details |
This web search service is supported by Google Inc.